Systematic Reviews of Treatments for Liver Diseases

Follow the links below to find summaries of systematic reviews of the evidence for treatments for liver diseases.

Created October 2007

Printer friendly page

39 Resources Found
Results 1 to 20 displayed.
1    2   
Title:   Hepatitis B immunisation in persons not previously exposed to hepatitis B or with unknown exposure status
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Several million people world-wide are infected with hepatitis B virus. The infection may cause serious short-term and long-term effects including portal hypertension, liver failure, liver cancer, and death. Hepatitis B vaccination is reported to be bene...
Date:   Jul 2008
Title:   Antacids for preventing oesophagogastric variceal bleeding and rebleeding in cirrhotic patients
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Randomised trials with antacids for preventing oesophagogastric variceal bleeding and bleeding in cirrhotic patients could not be found. Valid evidence for or against the use of antacids for preventing oesophagogastric variceal bleeding and bleeding in ...
Date:   Feb 2008
Title:   Systematic Reviews of Treatments for Cirrhosis of the Liver
Publisher:   HealthInsite Topic Page
Description:   Links to systematic reviews of the evidence for the effectiveness of treatments for cirrhosis of the liver.
Date:   Jan 2008
Title:   Methods of vascular occlusion for elective liver resections
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Intermittent vascular occlusion is safe in liver resectionMore than 1000 elective (planned operation) liver resections are performed annually in the United Kingdom alone. When liver resection is performed, the inflow of blood to the liver can be blocked...
Date:   Aug 2007
Title:   Cyclosporin A for primary biliary cirrhosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   The findings in this review are based on three clinical trials with 390 patients. The drug cyclosporin A was tested against placebo. The primary findings of the review are that cyclosporin A has no effect on survival or progression of the disease (cirrh...
Date:   May 2007
Title:   Azathioprine for primary biliary cirrhosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   The findings of this review are based on two clinical trials with 293 patients. The drug azathioprine was tested versus placebo or no intervention. The primary findings of the review are that azathioprine has no effect on survival, itching, progression ...
Date:   May 2007
Title:   Resection versus no intervention or other surgical interventions for colorectal cancer liver metastases
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   About one in four of patients with metastatic colorectal cancer have metastases isolated to the liver, of which 10-25% are eligible for ablation of the liver metastases. Preliminary data indicate that tumor ablation therapy can lead to improved survival...
Date:   May 2007
Title:   Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Non-alcoholic fatty liver disease is characterised by fatty deposition in the hepatocytes in the absence of excessive alcohol intake and of other known causes of fatty liver. Hepatic injury might be improved by antioxidant supplements. This systematic r...
Date:   Nov 2006
Title:   Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   No evidence to support or refute drugs trying to influence insulin resistance in patients with non-alcoholic fatty liver disease and/or steatohepatitis. Non-alcoholic fatty liver disease and steatohepatitis are clinical-pathological conditions characteris...
Date:   Nov 2006
Title:   Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   No evidence to support or refute probiotics for patients with non-alcoholic fatty liver disease and/or steatohepatitisProbiotics have been proposed as a treatment option for patients with non-alcoholic fatty liver disease and non-alcoholic steatohepatit...
Date:   Nov 2006
Title:   Elective surgery for benign liver tumours
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   No evidence to support or refute elective surgery for benign liver tumours. The most common benign liver tumours include cavernous haemangioma, focal nodular hyperplasia, and hepatic adenoma. The majority of patients are asymptomatic, and no treatment is ...
Date:   Nov 2006
Title:   Bicyclol for chronic hepatitis C
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Evidence on beneficial or harmful effects of bicyclol for chronic hepatitis C is not found. Bicyclol is a novel synthetic 'anti-hepatitis' drug, used primarily in China for patients with chronic hepatitis C. Only one small, short-term randomised clinical ...
Date:   Nov 2006
Title:   Bile acids for non-alcoholic fatty liver disease and/or steatohepatitis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Non-alcoholic fatty liver disease is a condition characterised by fatty deposition in the hepatocytes in patients with minimal or no alcohol intake. Hepatic injury might be improved by bile acids. This systematic review identified four randomised clinic...
Date:   Sep 2006
Title:   Human recombinant activated factor VII for upper gastrointestinal bleeding in patients with liver diseases
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   No sufficient evidence to prove with certainty that human recombinant activated factor VII reduces or not the risk of death in patients with liver disease suffering from upper gastrointestinal bleeding We could not test in a meta-analysis whether human ...
Date:   Aug 2006
Title:   Antifibrinolytic amino acids for acquired coagulation disorders in patients with liver disease
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Randomised clinical trials with antifibrinolytic amino acids for upper gastrointestinal bleeding in patients with liver disease plus acquired coagulation disorders could not be found....
Date:   Aug 2006
Title:   Bicyclol for chronic hepatitis B
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Evidence on beneficial or harmful effects of bicyclol for chronic hepatitis C is not found. Bicyclol is a novel synthetic 'anti-hepatitis' drug, used primarily in China for patients with chronic hepatitis B. No well-designed randomised clinical trials wer...
Date:   Aug 2006
Title:   TIPS versus paracentesis for cirrhotic patients with refractory ascites
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Patients with refractory ascites may temporarily benefit from transjugular intrahepatic portosystemic stent-shunts...
Title:   Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Portosystemic shunts compared with sclerotherapy/banding lowers variceal rebleeding, but increases hepatic encephalopathyA third of deaths from cirrhosis are due to variceal bleeding. Randomised clinical trials have compared three types of portosystemic...
Date:   Aug 2006
Title:   Anabolic-androgenic steroids for alcoholic liver disease
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Alcohol causes a major part of the liver diseases in the Western World. Several trials have addressed the effects of anabolic-androgenic steroids for alcoholic liver disease. This systematic review could not demonstrate any significant effects of anabol...
Date:   Aug 2006
Title:   Hepatic artery adjuvant chemotherapy for patients having resection or ablation of colorectal cancer metastatic to the liver
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Patients who die of colorectal cancer usually die from, or at least with, liver metastases. On the other hand, isolated liver metastases can, on occasion, be resected with a chance of cure, if metastatic disease is not present elsewhere. After liver res...
Date:   Jul 2006
Results 1 to 20 displayed.
1    2   

  • Other Related Topics: